Fecal microbiota transplantation: Emerging applications in autoimmune diseases.

Article Details

Citation
Copy to clipboard

Yang R, Chen Z, Cai J

Fecal microbiota transplantation: Emerging applications in autoimmune diseases.

J Autoimmun. 2023 Apr 26:103038. doi: 10.1016/j.jaut.2023.103038.

PubMed ID
37117118 [ View in PubMed
]
Abstract

Both genetic susceptibility and environmental factors are important contributors to autoimmune disease pathogenesis. As an environmental factor, the gut microbiome plays a crucial role in the development and progression of autoimmune diseases. Thus, strategies targeting gut microbiome alterations can potentially be used to treat autoimmune disease. Microbiota-based interventions, such as prebiotics, probiotics, dietary interventions, and fecal microbiota transplantation (FMT), have attracted growing interest as novel treatment approaches. FMT is an effective method for treating recurrent Clostridioides difficile infections; moreover, it is emerging as a promising treatment for patients with inflammatory bowel disease and other autoimmune diseases. Although the mechanisms underpinning the interaction between the gut microbiome and host are not fully understood in patients with autoimmune disease, FMT has been shown to restore altered gut microbiota composition, rebuild the intestinal microecosystem, and mediate innate and adaptive immune responses to achieve a therapeutic effect. In this review, we provide an overview of FMT and discuss how FMT can be used as a novel treatment approach for autoimmune diseases. Furthermore, we discuss recent challenges and offer future research directions.

DrugBank Data that Cites this Article

Drugs